Business Description
enVVeno Medical Corp
NAICS : 339113
SIC : 3841
ISIN : US29415J1060
Share Class Description:
NVNO: Ordinary SharesTotal Employee Number:
33Description
enVVeno Medical Corp is a medical device company focused on the advancement of bioprosthetic (tissue-based) solutions to improve the standard of care for the treatment of venous disease. The company first developed the VenoValve, which was a surgical replacement venous valve. It is focused on its next-generation, non-surgical venous valve product, called the enVVe System which consists of the enVVe Valve, enVVe Delivery System, enVVe Nose Cone, the enVVe Delivery System Accessories, and the enVVe Crimping System. The enVVe System is designed to treat severe deep chronic venous insufficiency through a minimally invasive, catheter-based approach. It operates in a single segment, Medical Device development, located in a single geographic location, the United States.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 41.34 | |||||
Equity-to-Asset | 0.91 | |||||
Debt-to-Equity | 0.03 | |||||
Debt-to-EBITDA | -0.03 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | 3/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 23 | |||||
3-Year EPS without NRI Growth Rate | 23.7 | |||||
3-Year FCF Growth Rate | 18.6 | |||||
3-Year Book Growth Rate | -33.9 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 22.17 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 48.71 | |||||
9-Day RSI | 52.47 | |||||
14-Day RSI | 52.7 | |||||
3-1 Month Momentum % | -9.5 | |||||
6-1 Month Momentum % | -14.46 | |||||
12-1 Month Momentum % | -93.16 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 11.89 | |||||
Quick Ratio | 11.89 | |||||
Cash Ratio | 11.63 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -34.3 | |||||
Shareholder Yield % | 4.93 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROE % | -62.03 | |||||
ROA % | -56.97 | |||||
ROIC % | -1045.19 | |||||
3-Year ROIIC % | -383.37 | |||||
ROC (Joel Greenblatt) % | -2432.17 | |||||
ROCE % | -65.03 | |||||
Moat Score | 4 | |||||
Tariff Resilience Score | 7 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PB Ratio | 0.31 | |||||
Price-to-Tangible-Book | 0.31 | |||||
EV-to-EBIT | 0.84 | |||||
EV-to-EBITDA | 0.87 | |||||
EV-to-Forward-Revenue | 442.93 | |||||
EV-to-FCF | 1.14 | |||||
| Price-to-Net-Current-Asset-Value | 0.32 | |||||
| Price-to-Net-Cash | 0.32 | |||||
Earnings Yield (Greenblatt) % | 119.05 | |||||
FCF Yield % | -199.19 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:NVNO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
enVVeno Medical Corp Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -31.25 | ||
| Beta | 1.3128 | ||
| 3-Year Sharpe Ratio | -0.29 | ||
| 3-Year Sortino Ratio | -0.38 | ||
| Volatility % | 98.03 | ||
| 14-Day RSI | 52.7 | ||
| 14-Day ATR ($) | 0.789834 | ||
| 20-Day SMA ($) | 10.72949 | ||
| 12-1 Month Momentum % | -93.16 | ||
| 52-Week Range ($) | 8.67 - 196.699999 | ||
| Shares Outstanding (Mil) | 0.67 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
enVVeno Medical Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
enVVeno Medical Corp Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| General meeting for 2026 | 2026-12-11 09:00 | In 151 days | ||
| Third quarter earnings results for 2026 | 2026-10-30 | In 108 days | ||
| Second quarter earnings results for 2026 | 2026-07-31 | In 17 days | ||
| First quarter earnings results for 2026 | 2026-05-06 | 10.38 (-3.89%) | ||
| Annual report for 2025 | 2026-03-26 | 10.98 (+0.79%) | ||
| 0.0285714:1 Stock Split | 2026-01-20 | 11.97 (+12.13%) | ||
| General meeting for 2025 | 2025-12-11 09:00 | 12.16 (+0.20%) | ||
| Live Virtual Investor CEO Connect segment on | 2025-12-03 16:00 | 12.73 (-7.01%) | ||
| Third quarter earnings results for 2025 | 2025-10-31 | 24.40 (-0.40%) | ||
| Second quarter earnings results for 2025 | 2025-08-01 | 161.35 (-6.68%) |
Show
Entries
enVVeno Medical Corp Frequently Asked Questions
What is enVVeno Medical Corp(NVNO)'s stock price today?
The current price of NVNO is $11.12. The 52 week high of NVNO is $196.70 and 52 week low is $8.67.
When is next earnings date of enVVeno Medical Corp(NVNO)?
The next earnings date of enVVeno Medical Corp(NVNO) is 2026-07-31 Est..
Does enVVeno Medical Corp(NVNO) pay dividends? If so, how much?
enVVeno Medical Corp(NVNO) does not pay dividend.
Guru Commentaries on NAS:NVNO
No articles.
Press Release
Articles on enVVeno Medical Corp
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers